You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NAGE Award Disclosure
Pamir Ozan · SEC Form 4 · Filed Jul 8, 2026
Award
Calculated transaction value
$11.53K
Pamir Ozan Chief Financial Officer
NAGE
Niagen Bioscience
NAGE
Transaction date
Jun 30, 2026
Public filing date
Jul 8, 2026
Filing lag
Filed 8 days later
NAGE daily price context
Close on/before transaction
$3.19
Jun 30, 2026
First close after public filing
$3.49
Jul 9, 2026
30-day return after filing
-10.6%
Through Aug 7, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,255 shares @ $2.71
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001834681-26-000001
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$11.53K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Niagen Bioscience, Inc. NAGE Current | Award | Jun 30, 2026 | $11.53K |